The Current Role of PET/CT in Radiotherapy Planning

Title:The Current Role of PET/CT in Radiotherapy Planning

Volume: 8 Issue: 1

Author(s): Sze Ting Lee and Andrew M. Scott

Affiliation:

• Department of Molecular Imaging and Therapy, Austin Health Level 1, Harold Stokes Building, Studley Road, Heidelberg, VIC, 3084, Australia.,Australia

Keywords: PET/CT, radiotherapy planning, FDG, IMRT, head & neck carcinoma, lung carcinoma, gastrointestinal carcinoma, gynaecological carcinoma.

Abstract: Positron Emission Tomography (PET) is increasingly being used in radiotherapy planning, with the development of hybrid imaging technology such as PET/CT allowing more accurate volumes being generated for treatment with external beam radiation. This article will discuss the use of FDG PET in radiotherapy planning of various types of malignancies, as well as some pitfalls and practicalities of integrating PET/CT into radiotherapy planning.

Cite this article as:

Lee Ting Sze and Scott M. Andrew, The Current Role of PET/CT in Radiotherapy Planning, Current Radiopharmaceuticals 2015; 8(1) . https://dx.doi.org/10.2174/1874471008666150316222618